Skip to content

US · BCTXZ

BriaCell Therapeutics Corp. Warrant

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
West Vancouver, BC V7T 2X1

Price · as of 2026-09-04

$0.19

Market cap 163.51K

Price history

Weekly OHLC price history for BCTXZ, USD per share
WeekOpenHighLowCloseVolume
Apr 21, 2025 – Apr 25, 2025$0.99$1.51$0.99$1.31
Apr 28, 2025 – May 2, 2025$1.31$1.35$1.10$1.180
May 5, 2025 – May 9, 2025$1.16$1.20$0.93$0.940
May 12, 2025 – May 16, 2025$1.11$1.13$0.91$1.010
May 19, 2025 – May 23, 2025$1.07$1.18$1.02$1.070
May 26, 2025 – May 30, 2025$0.99$1.10$0.99$1.100
Jun 2, 2025 – Jun 6, 2025$1.10$1.11$0.99$1.050
Jun 9, 2025 – Jun 13, 2025$0.94$1.14$0.91$0.990
Jun 16, 2025 – Jun 20, 2025$0.99$1.02$1.00$1.020
Jun 23, 2025 – Jun 26, 2025$0.92$1.07$0.91$1.070
Jun 30, 2025 – Jul 3, 2025$1.06$1.07$0.93$1.060
Jul 7, 2025 – Jul 11, 2025$0.90$1.06$0.50$0.500
Jul 14, 2025 – Jul 18, 2025$0.50$0.59$0.18$0.350
Jul 21, 2025 – Jul 25, 2025$0.34$0.35$0.19$0.350
Jul 28, 2025 – Aug 1, 2025$0.24$0.35$0.18$0.280
Aug 4, 2025 – Aug 8, 2025$0.21$0.31$0.19$0.270
Aug 11, 2025 – Aug 15, 2025$0.29$0.29$0.20$0.250
Aug 18, 2025 – Aug 22, 2025$0.27$0.27$0.16$0.220
Aug 25, 2025 – Aug 29, 2025$0.26$0.26$0.12$0.160
Sep 1, 2025 – Sep 5, 2025$0.19$0.22$0.18$0.190
Sep 8, 2025 – Sep 12, 2025$0.22$0.22$0.17$0.210
Sep 15, 2025 – Sep 19, 2025$0.19$0.22$0.17$0.210
Sep 22, 2025 – Sep 26, 2025$0.18$0.42$0.18$0.280
Sep 29, 2025 – Oct 3, 2025$0.32$0.50$0.28$0.450
Oct 6, 2025 – Oct 10, 2025$0.50$0.52$0.37$0.450
Oct 13, 2025 – Oct 17, 2025$0.43$0.45$0.37$0.410
Oct 20, 2025 – Oct 24, 2025$0.36$0.47$0.32$0.460
Oct 27, 2025 – Oct 30, 2025$0.38$0.48$0.38$0.400
Nov 3, 2025 – Nov 7, 2025$0.41$0.43$0.26$0.300
Nov 10, 2025 – Nov 14, 2025$0.37$0.39$0.29$0.380
Nov 17, 2025 – Nov 21, 2025$0.34$0.32$0.28$0.290
Nov 24, 2025 – Nov 26, 2025$0.25$0.38$0.25$0.370
Dec 1, 2025 – Dec 5, 2025$0.36$0.44$0.35$0.390
Dec 8, 2025 – Dec 12, 2025$0.38$0.42$0.35$0.360
Dec 15, 2025 – Dec 18, 2025$0.36$0.40$0.31$0.390
Dec 22, 2025 – Dec 24, 2025$0.30$0.30$0.26$0.300
Dec 29, 2025 – Jan 2, 2026$0.30$0.29$0.16$0.250
Jan 5, 2026 – Jan 9, 2026$0.24$0.30$0.22$0.270
Jan 12, 2026 – Jan 16, 2026$0.29$0.38$0.14$0.200
Jan 19, 2026 – Jan 23, 2026$0.16$0.23$0.14$0.170
Jan 26, 2026 – Jan 30, 2026$0.16$0.20$0.14$0.190
Feb 2, 2026 – Feb 6, 2026$0.19$0.20$0.14$0.180
Feb 9, 2026 – Feb 13, 2026$0.14$0.19$0.13$0.150
Feb 16, 2026 – Feb 20, 2026$0.18$0.19$0.13$0.170
Feb 23, 2026 – Feb 27, 2026$0.17$0.17$0.12$0.170
Mar 2, 2026 – Mar 6, 2026$0.17$0.17$0.14$0.150
Mar 9, 2026 – Mar 13, 2026$0.15$0.17$0.06$0.160
Mar 16, 2026 – Mar 20, 2026$0.11$0.16$0.11$0.110
Mar 23, 2026 – Mar 27, 2026$0.11$0.13$0.11$0.130
Mar 30, 2026 – Apr 2, 2026$0.13$0.15$0.10$0.110
Apr 6, 2026 – Apr 10, 2026$0.14$0.15$0.14$0.150
Apr 13, 2026 – Apr 17, 2026$0.14$0.15$0.11$0.140
Apr 20, 2026 – Apr 24, 2026$0.14$0.15$0.10$0.110
Apr 27, 2026 – May 1, 2026$0.12$0.12$0.08$0.090
May 4, 2026 – May 8, 2026$0.08$0.11$0.07$0.090
May 11, 2026 – May 15, 2026$0.09$0.09$0.06$0.080
May 18, 2026 – May 22, 2026$0.08$0.08$0.07$0.080
May 25, 2026 – May 29, 2026$0.08$0.09$0.06$0.080
Jun 1, 2026 – Jun 5, 2026$0.08$0.08$0.06$0.080
Jun 8, 2026 – Jun 12, 2026$0.08$0.09$0.06$0.080
Jun 15, 2026 – Jun 18, 2026$0.07$0.08$0.07$0.080
Jun 22, 2026 – Jun 26, 2026$0.08$0.08$0.07$0.080
Jun 29, 2026 – Jul 2, 2026$0.08$0.11$0.07$0.090
Jul 6, 2026 – Jul 10, 2026$0.08$0.11$0.07$0.100
Jul 13, 2026 – Jul 17, 2026$0.10$0.10$0.09$0.100
Jul 20, 2026 – Jul 24, 2026$0.09$0.12$0.09$0.100
Jul 27, 2026 – Jul 31, 2026$0.10$0.11$0.07$0.090
Aug 3, 2026 – Aug 7, 2026$0.09$0.11$0.07$0.090
Aug 10, 2026 – Aug 14, 2026$0.11$0.14$0.08$0.110
Aug 17, 2026 – Aug 21, 2026$0.11$0.17$0.09$0.110
Aug 24, 2026 – Aug 28, 2026$0.12$0.17$0.11$0.140
Aug 31, 2026 – Sep 4, 2026$0.16$0.25$0.13$0.190

Valuation

MetricValueUpside
IC Value
P/E
P/B
P/S
EV/EBITDA
PEG
P/TBV

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for BCTXZ, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About BriaCell Therapeutics Corp. Warrant

        BriaCell Therapeutics Corp., a biotechnology company based in West Vancouver, Canada, is intensely focused on immuno-oncology, dedicated to engineering novel immunotherapies for cancer treatment. Its flagship compound, Bria-IMT, is a whole-cell cancer vaccine presently in Phase I/IIa clinical development, where it's being evaluated in conjunction with the investigational immunotherapy retifanlimab. The company's pipeline also includes Bria-OTS, a personalized, ready-to-use immunotherapy intended for advanced breast cancer, and BriaDx, a diagnostic tool for determining patient HLA types. BriaCell maintains a non-exclusive clinical trial collaboration with Incyte Corporation to explore the effects of combining various novel clinical candidates. Furthermore, a cooperative research and development agreement with the National Cancer Institute supports preclinical efforts to advance and test Bria-OTS cellular immunotherapy as a cancer therapy.

        CEO
        William V. Williams
        Employees
        16
        Beta
        1.54

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for BCTXZ: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        BCTXZBriaCell Therapeutics Cor…$0.09163.51K0.00%0.00%0.00%-342.34%1705.16%-193.02%0.00-735.715.014.630.3844.12%16.00%-7.141765.69%0.00%
        AIMDAinos, Inc.$1.4910.97M$41.70+2,698%-0.410.8048.50-1.79-0.33-0.52-3767.20%-11268.32%-11897.04%-128.00%-66.99%-59.45%1.45-19.651.060.39-1.14121.79%498.95%-20.25%-77.21%-4.28-22.26%0.00%0.00%0.00%-1.19-3.57133.74-6.46
        DRMADermata Therapeutics, Inc…$1.10749.71K0.000.180.830.180.00%0.00%0.00%-194195.70%536.28%-132632.86%0.004.794.590.97-89.84%69393.82%-703845.08%-4728.93535174.96%0.00%0.00%395.65%0.830.00-14.95
        ELABPMGC Holdings Inc.$0.924.16M$142.05+15,416%-0.010.010.160.370.0212.68%-1250.11%-1306.28%-106.89%-190.24%-70.88%0.34-13.481.741.460.38-94.25%-76.08%16.12%-6846.89%-1.51-164.59%0.00%0.00%0.19%0.360.42-4.51-3.85
        MLECMoolec Science S.A.$7.195.22M$506.41+6,943%-0.07-0.120.02-3.560.00-0.0534.17%-3.14%-33.41%376.84%-11.15%-93.08%-3.74-0.250.130.12-3.578978.95%5830.74%217.33%-393.07%-0.10-32.03%0.00%0.00%12.10%-23.43-8.160.74-0.48
        NCELNewcelX Ltd.$3.311.49M-1.271.45-3.88-11.470.00%0.00%0.00%-191.77%-96.17%-121.36%0.05-0.410.760.520.83-91.79%-35.06%-26.34%-0.66-107.83%0.00%0.00%1.71%-3.51-3.13-9.70
        VRAXVirax Biolabs Group Limit…$2.9859.37M$23.47+687%-0.420.28170.360.660.2861.90%-51515.17%-40439.10%-75.70%-385.79%-68.11%0.05-103.609.979.521.00-74.07%96.22%-5.61%-230.47%-6.75-294.04%0.00%0.00%102.65%0.620.82-320.97-5.35
        XRTXXORTX Therapeutics Inc.$2.13593.18K-0.140.180.140.200.00%0.00%0.00%-99.82%-307.32%-79.84%0.021.611.580.26-48.27%-20.44%-741.92%-4.71-261.32%0.00%0.00%0.00%0.130.16-15.97

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.19) − 1 = — (IC, example).